Kate Gifford 
Here we explore an overview of spectacle prescribing for myopia management – from when to use single vision, to progressive and bifocal designs, new myopia control specific designs, and whether to fully or under-correct.
Professor Karla Zadnik, Dean of the Ohio State University College of Optometry in the USA,, discusses the Childhood Atropine for Myopia Progression (CHAMP) study, engaging with the literature, her favourite papers and an alternative take on myopia control as standard of care.
As technology evolves the next big change is likely to be Virtual Reality. Could we expect Virtual Reality to be better for myopia than our screens and smartphones of today? How will the artificially simulated visual environment of VR impact on children’s visual development? Let’s explore what we know and what we’re yet to learn.
This GSLS 2020 update compares the risk of vision loss with contact lens wear to vision saved by reducing final myopia.
Podcast summary: Dr Monica Jong, Executive Director of the International Myopia Institute, founded by the Brien Holden Vision Institute, tells
Podcast summary: Philip Cheng, well-known clinical optometrist from Melbourne, Australia and prolific contributor to the Myopia Profile Facebook group, takes
Podcast summary: Professor Mark Bullimore of the University of Houston, Texas USA, tells us more on the complex topic of
Podcast summary: Lyndon and Debbie Jones from the Centre for Ocular Research and Education and University of Waterloo, Canada, highlight
Podcast summary: Professor James Loughman from Technological University Dublin, and the Centre for Eye Research Ireland, challenges us to think
There’s a little more to think about in the important role spectacle lenses play in myopia management. Even if we prescribe contact lenses, our young myopes are most likely to need a back up spectacle lens option. Children prescribed atropine will need the best spectacle lens prescribed for them to minimise the impact of any side effects.
